Table 1.
Descriptive characteristics of the sample (N = 182)
| Age, M (SD) | 60.1 (13.1) |
| Female, n (%) | 96 (52.7) |
| Race/Ethnicity, n (%) | |
| White | 132 (72.5) |
| Black | 8 (4.4) |
| Hispanic/Latino | 21 (11.5) |
| Asian/Pacific Islander | 13 (7.1) |
| Other | 8 (4.4) |
| Cancer site, n (%) | |
| Genitourinary | 40 (22.0) |
| Breast | 39 (21.4) |
| Gastrointestinal | 34 (18.7) |
| Hematologic | 17 (9.4) |
| Respiratory | 15 (8.2) |
| Lymphoma | 9 (5.0) |
| Neurologic | 9 (5.0) |
| Head and Neck | 7 (3.8) |
| Musculoskeletal | 5 (2.7) |
| Neuroendocrine | 4 (2.2) |
| Other | 3 (1.6) |
| DCCI, M (SD) | 1.7 (2.2) |
| Metastatic disease, n (%) | 59 (32.4) |
| Annual mental health visits, M (SD) | 3.6 (7.9) |
Note. DCCI = Deyo-Charlson Comorbidity Index.